BeOne Medicines (ONC) Net Cash Flow Growth (3y) (2018 - 2026)
BeOne Medicines (ONC) Net Cash Flow Growth (3y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 38.47% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 33.37% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -29.82% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Alnylam Pharmaceuticals | 36.08 Bn | 33.07 Bn | 959.66 Mn | 32.17% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 38.47% |
| Dec 31, 2025 | 47.67% |
| Sep 30, 2025 | 89.73% |
| Jun 30, 2025 | -3.87% |
| Mar 31, 2025 | -43.94% |
| Dec 31, 2024 | -26.13% |
| Sep 30, 2024 | 29.44% |
| Jun 30, 2024 | -11.34% |
| Mar 31, 2024 | -38.89% |
| Dec 31, 2023 | 38.75% |
| Sep 30, 2023 | -71.78% |
| Jun 30, 2023 | 53.88% |
| Mar 31, 2023 | -31.13% |
| Dec 31, 2022 | -10.52% |
| Sep 30, 2022 | -118.07% |
| Jun 30, 2022 | 17.43% |
| Mar 31, 2022 | -41.99% |
| Dec 31, 2021 | 393.81% |
| Sep 30, 2021 | -53.32% |
| Jun 30, 2021 | -54.01% |